Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19 - Coronavirus Updates

Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.

Read More >>